GPT Healthcare Ltd
Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services[1]
- Market Cap ₹ 1,130 Cr.
- Current Price ₹ 138
- High / Low ₹ 185 / 114
- Stock P/E 27.9
- Book Value ₹ 30.9
- Dividend Yield 1.81 %
- ROCE 27.2 %
- ROE 21.3 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 67.9%
Cons
- Promoter holding has decreased over last 3 years: -34.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 212 | 243 | 337 | 361 | 400 | 407 | 448 | |
| 176 | 194 | 263 | 287 | 312 | 324 | 366 | |
| Operating Profit | 36 | 49 | 74 | 74 | 88 | 83 | 82 |
| OPM % | 17% | 20% | 22% | 21% | 22% | 20% | 18% |
| 4 | 6 | 5 | 6 | 5 | 8 | 6 | |
| Interest | 14 | 14 | 11 | 9 | 7 | 3 | 7 |
| Depreciation | 11 | 12 | 14 | 15 | 18 | 19 | 25 |
| Profit before tax | 15 | 29 | 54 | 56 | 68 | 69 | 55 |
| Tax % | 26% | 27% | 23% | 30% | 30% | 28% | |
| 11 | 21 | 42 | 39 | 48 | 50 | 41 | |
| EPS in Rs | 6.11 | 11.76 | 5.21 | 4.88 | 5.82 | 6.08 | 4.94 |
| Dividend Payout % | -0% | 47% | -0% | 102% | 60% | 41% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 6% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 6% |
| TTM: | -19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 23% |
| 3 Years: | 23% |
| Last Year: | 21% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 18 | 18 | 80 | 80 | 82 | 82 | 82 |
| Reserves | 109 | 116 | 78 | 85 | 136 | 166 | 172 |
| 157 | 166 | 102 | 82 | 31 | 35 | 97 | |
| 25 | 18 | 63 | 79 | 96 | 101 | 113 | |
| Total Liabilities | 308 | 317 | 323 | 327 | 346 | 384 | 463 |
| 226 | 220 | 220 | 228 | 224 | 228 | 342 | |
| CWIP | 2 | 0 | 1 | 3 | 6 | 46 | 2 |
| Investments | 1 | 1 | 10 | 13 | 30 | 32 | 32 |
| 80 | 97 | 92 | 83 | 85 | 78 | 87 | |
| Total Assets | 308 | 317 | 323 | 327 | 346 | 384 | 463 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 41 | 43 | 66 | 66 | 69 | 67 | |
| -54 | -16 | -5 | 5 | -25 | -33 | |
| 12 | -22 | -57 | -73 | -48 | -35 | |
| Net Cash Flow | -1 | 4 | 3 | -2 | -5 | -0 |
| Free Cash Flow | -5 | 38 | 59 | 58 | 50 | 18 |
| CFO/OP | 116% | 88% | 107% | 103% | 95% | 101% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 30 | 26 | 15 | 21 | 22 | 18 |
| Inventory Days | 60 | 41 | 30 | 43 | 36 | 41 |
| Days Payable | 314 | 165 | 121 | 161 | 165 | 161 |
| Cash Conversion Cycle | -224 | -98 | -76 | -97 | -106 | -102 |
| Working Capital Days | -4 | 32 | 3 | -18 | -16 | -28 |
| ROCE % | 14% | 23% | 25% | 30% | 27% |
Insights
In beta| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Number of Beds (Capacity) Number |
|
|||||
| Average Length of Stay (ALOS) Days |
||||||
| Average Revenue per Occupied Bed (ARPOB) INR |
||||||
| Inpatient Volume Number |
||||||
| Occupancy Rate % |
||||||
| Outpatient Volume Number |
||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
10 Apr - Submitted Regulation 74(5) certificate for quarter ended March 31, 2026; no demat/remat requests received.
-
Announcement under Regulation 30 (LODR)-Change in Management
2 Apr - Debashis Dhar resigned as Senior VP and Chief Business Development Officer, effective April 2, 2026.
- Closure of Trading Window 26 Mar
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 Mar - For Investor Meet on Tuesday, March 10, 2026.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 Mar - For Investor meet on Friday, February 6, 2026.
Concalls
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Mar 2024Transcript PPT
Business Overview:[1]
GPT Healthcare Limited operates as a key regional corporate healthcare provider in Eastern India under the ILS Hospitals brand. The organization has established 5 multi-specialty hospitals with a total capacity of 719 beds, supported by 91 full-time consultants and 630 visiting consultants.